Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint...

por Chesney, Jason, Lewis, Karl D, Kluger, Harriet, Hamid, Omid, Whitman, Eric, Thomas, Sajeve, Wermke, Martin, Cusnir, Mike, Domingo-Musibay, Evidio, Phan, Giao Q, Kirkwood, John M, Hassel, Jessica C, Orloff, Marlana, Larkin, James, Weber, Jeffrey, Furness, Andrew J S, Khushalani, Nikhil I, Medina, Theresa, Egger, Michael E, Graf Finckenstein, Friedrich, Jagasia, Madan, Hari, Parameswaran, Sulur, Giri, Shi, Wen, Wu, Xiao, Sarnaik, Amod
Publicado 2022

Lifileucel, a Tumor-Infiltrating Lymphocyte Therapy, in Metastatic Melanoma

por Sarnaik, Amod A., Hamid, Omid, Khushalani, Nikhil I., Lewis, Karl D., Medina, Theresa, Kluger, Harriet M., Thomas, Sajeve S., Domingo-Musibay, Evidio, Pavlick, Anna C., Whitman, Eric D., Martin-Algarra, Salvador, Corrie, Pippa, Curti, Brendan D., Oláh, Judit, Lutzky, Jose, Weber, Jeffrey S., Larkin, James M. G., Shi, Wen, Takamura, Toshimi, Jagasia, Madan, Qin, Harry, Wu, Xiao, Chartier, Cecile, Graf Finckenstein, Friedrich, Fardis, Maria, Kirkwood, John M., Chesney, Jason A.
Publicado 2021